Literature DB >> 15292818

Modulation of distraction osteogenesis in the aged rat by fibroblast growth factor.

James Aronson1.   

Abstract

This study explores a series of hypotheses related to modulation of bone formation using the distraction model. The tibial lengthening model was scaled down from dog to rat to use immunohistochemistry, in situ hybridization, and reverse transcription-polymerase chain reaction to evaluate cellular events during in vivo bone formation. Different delivery systems such as oral, intragastric, intravenous, subcutaneous, and local diffusion by either extraperiosteal or intramedullary routes, were developed and standardized. Systemic modulators, including diet (total enteral nutrition, calcium, phosphate, soy, whey, casein, lead, and alcohol) and hormones (estrogen, testosterone, growth hormone, and gonadectomy), were tested. To investigate the effects of aging on bone formation, rats of different age groups had tibial lengthening. The aging effect could be distinguished by a reproducible deficiency of endosteal bone formation, consistent with similar deficits in older adult patients having distraction osteogenesis or in patients with senile osteoporosis. Expression of endogenous fibroblast growth factor-2 at the cellular level during the coupled osteogenesis and angiogenesis in young rats was dramatically diminished in old rats. Exogenous fibroblast growth factor-2 reversed the endosteal deficits found in old rats having distraction osteogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15292818     DOI: 10.1097/01.blo.0000138186.53426.f9

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  8 in total

1.  Effects of systemic and local administration of recombinant human IGF-I (rhIGF-I) on de novo bone formation in an aged mouse model.

Authors:  John L Fowlkes; Kathryn M Thrailkill; Lichu Liu; Elizabeth C Wahl; Robert C Bunn; Gael E Cockrell; Daniel S Perrien; James Aronson; Charles K Lumpkin
Journal:  J Bone Miner Res       Date:  2006-09       Impact factor: 6.741

2.  Inhibin A enhances bone formation during distraction osteogenesis.

Authors:  Daniel S Perrien; Kristy M Nicks; Lichu Liu; Nisreen S Akel; Anthony W Bacon; Robert A Skinner; Frances L Swain; James Aronson; Larry J Suva; Dana Gaddy
Journal:  J Orthop Res       Date:  2011-08-01       Impact factor: 3.494

3.  Rosiglitazone inhibits bone regeneration and causes significant accumulation of fat at sites of new bone formation.

Authors:  Lichu Liu; James Aronson; Shilong Huang; Yalin Lu; Piotr Czernik; Sima Rahman; Vipula Kolli; Larry J Suva; Beata Lecka-Czernik
Journal:  Calcif Tissue Int       Date:  2012-07-01       Impact factor: 4.333

4.  Rosiglitazone disrupts endosteal bone formation during distraction osteogenesis by local adipocytic infiltration.

Authors:  Lichu Liu; James Aronson; Beata Lecka-Czernik
Journal:  Bone       Date:  2012-10-13       Impact factor: 4.398

5.  Runt-related transcription factor 2 (RUNX2) and RUNX2-related osteogenic genes are down-regulated throughout osteogenesis in type 1 diabetes mellitus.

Authors:  John L Fowlkes; R Clay Bunn; Lichu Liu; Elizabeth C Wahl; Hannah N Coleman; Gael E Cockrell; Daniel S Perrien; Charles K Lumpkin; Kathryn M Thrailkill
Journal:  Endocrinology       Date:  2007-12-27       Impact factor: 4.736

6.  Recombinant human bone morphogenetic protein-2 suspended in fibrin glue enhances bone formation during distraction osteogenesis in rabbits.

Authors:  Yunfeng Li; Rui Li; Jing Hu; Donghui Song; Xiaowen Jiang; Songsong Zhu
Journal:  Arch Med Sci       Date:  2016-05-18       Impact factor: 3.318

7.  Exosomes secreted by endothelial progenitor cells accelerate bone regeneration during distraction osteogenesis by stimulating angiogenesis.

Authors:  Yachao Jia; Yu Zhu; Shuo Qiu; Jia Xu; Yimin Chai
Journal:  Stem Cell Res Ther       Date:  2019-01-11       Impact factor: 6.832

8.  MicroRNA-205 mediates endothelial progenitor functions in distraction osteogenesis by targeting the transcription regulator NOTCH2.

Authors:  Weidong Jiang; Peiqi Zhu; Tao Zhang; Fengchun Liao; Yangyang Yu; Yan Liu; Huijuan Shen; Zhenchen Zhao; Xuanping Huang; Nuo Zhou
Journal:  Stem Cell Res Ther       Date:  2021-02-03       Impact factor: 6.832

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.